Alerts will be sent to your verified email
Verify Email
VISAMAN
|
Visaman Global Sales
|
ABans Enterprises
|
Balaxi Pharma.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
10.75 % | 10.81 % | 27.3 % |
|
5yr average Equity Multiplier
|
6.08 | 2.03 | 1.4 |
|
5yr Average Asset Turnover Ratio
|
5.58 | 7.47 | 1.43 |
|
5yr Avg Net Profit Margin
|
0.33 % | 0.73 % | 11.03 % |
|
Price to Book
|
0.0 | 1.14 | 1.02 |
|
P/E
|
110.43 | 12.35 | 12.55 |
|
5yr Avg Cash Conversion Cycle
|
61.81 Days | 25.62 Days | 154.28 Days |
|
Inventory Days
|
17.96 Days | 11.91 Days | 87.41 Days |
|
Days Receivable
|
35.06 Days | 15.45 Days | 103.86 Days |
|
Days Payable
|
18.89 Days | 10.15 Days | 63.18 Days |
|
5yr Average Interest Coverage Ratio
|
1.64 | 3.6 | 57.05 |
|
5yr Avg ROCE
|
29.39 % | 16.3 % | 36.52 % |
|
5yr Avg Operating Profit Margin
|
1.02 % | 0.96 % | 16.64 % |
|
5 yr average Debt to Equity
|
3.15 | 0.67 | 0.09 |
|
5yr CAGR Net Profit
|
50.44 % | -10.28 % | -5.76 % |
|
5yr Average Return on Assets
|
1.77 % | 5.67 % | 18.47 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.35 % | 74.56 % | 65.99 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.37 % | 0.0 | -6.87 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Visaman Global Sales
|
ABans Enterprises
|
Balaxi Pharma.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|